Skip to main content
. 2022 Nov 10;13:6807. doi: 10.1038/s41467-022-34403-5

Fig. 1. Study design and Consort diagram.

Fig. 1

a Trial schema and sample collection. b Consort diagram. XELOX, capecitabine and oxaliplatin, WES whole-exome sequencing.